Attached files
| file | filename |
|---|---|
| EX-21.1 - EX-21.1 - IMMUNOMEDICS INC | d28769dex211.htm |
| EX-32.1 - EX-32.1 - IMMUNOMEDICS INC | d28769dex321.htm |
| EX-31.2 - EX-31.2 - IMMUNOMEDICS INC | d28769dex312.htm |
| EX-31.1 - EX-31.1 - IMMUNOMEDICS INC | d28769dex311.htm |
| EX-23.2 - EX-23.2 - IMMUNOMEDICS INC | d28769dex232.htm |
| 10-K - FORM 10-K - IMMUNOMEDICS INC | d28769d10k.htm |
| EX-32.2 - EX-32.2 - IMMUNOMEDICS INC | d28769dex322.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Immunomedics, Inc.
We consent to the incorporation by reference in the Registration Statements Nos. 333-198766, 333-184377, 333-128310, 333-114810 and 333-90338 on Form S-3 and the Registration Statements Nos. 333-201470, 333-143420 and 333-53224 on Form S-8 of Immunomedics, Inc. of our reports dated August 19, 2015, with respect to the consolidated balance sheets of Immunomedics, Inc. and subsidiaries as of June 30, 2015 and 2014, the related consolidated statements of comprehensive loss, changes in stockholders’ (deficit) equity and cash flows for the years then ended, and the related financial statement schedule, and the effectiveness of internal control over financial reporting as of June 30, 2015, which reports appear in the June 30, 2015 annual report on Form 10-K of Immunomedics, Inc.
/s/ KPMG LLP
Short Hills, New Jersey
August 19, 2015